ABL1 and Parkinsonism: Studies so far carried out to exhibit the effect of Tasigna as an active therapeutic molecule for the neurodegenerative disease is in concern with C-ABL inhibition and some studies are also focused on autophagic clearance of α-SYNUCLEIN and amyloid aggregates in Parkinson’s and Alzheimer’s disease respectively.